Cost-utility Analysis of Outpatient Manual Vacuum Aspiration Versus Operating Room Electric Aspiration for the Management of First-trimester Miscarriage (ASPIR)
Cost-utility Analysis of Outpatient Manual Vacuum Aspiration Versus Operating Room Electric Aspiration for the Management of First-trimester Miscarriage (ASPIR Study)
Visão geral do estudo
Status
Intervenção / Tratamento
Descrição detalhada
Miscarriage occurs in approximately 15% of pregnancies during the first trimester. In France, surgical management usually involves electric aspiration in the operating room under anesthesia, associated with hospital admission. Manual vacuum aspiration (MVA) is widely used in low-resource settings and for induced abortion, with demonstrated safety and patient satisfaction. This multicenter randomized controlled trial compares outpatient MVA under local anesthesia and inhaled analgesia versus electric aspiration (EA) under anesthesia in the operating room.
The primary objective is to assess the incremental cost-utility ratio (ICUR, cost per QALY) at 3 months. Secondary outcomes include complications, pain, satisfaction, quality of life, and fertility at 12 months. The study anticipates enrolling 860 participants across multiple centers in France.
Tipo de estudo
Inscrição (Estimado)
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
- Nome: Thibault Thubert, Pr
- Número de telefone: +33253482443
- E-mail: thibault.thubert@chu-nantes.fr
Locais de estudo
-
-
-
Nantes, França, 44000
- CHU de Nantes
-
Contato:
- Thibault Thubert, Pr
- Número de telefone: +33 2 53 48 24 43
- E-mail: thibault.thubert@chu-nantes.fr
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
- Adulto
Aceita Voluntários Saudáveis
Descrição
Inclusion Criteria:
- Female, aged 18-44 years
- Ultrasound-confirmed first-trimester miscarriage requiring surgical management
- Gestational age between 5 and 12 weeks of amenorrhea
- Incomplete spontaneous abortion or ongoing non-viable pregnancy
- Patient able to provide oral informed consent
Exclusion Criteria:
- Complete expulsion of pregnancy (endometrial thickness < 15 mm)
- Choice of medical treatment with misoprostol
- Elective termination of pregnancy
- Unwanted pregnancy
- Pregnancy of unknown location, molar pregnancy
- Known uterine malformation
- Prior surgical aspiration for the current pregnancy
- Intrauterine device in place
- Contraindicating medications (e.g. anticoagulants)
- Protected adults (under guardianship)
- Inability to complete study questionnaires
- Lack of social security coverage
- Haemorrhagic miscarriage
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Pesquisa de serviços de saúde
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Manual vacuum aspiration (MVA)
Outpatient manual vacuum aspiration under local anesthesia and inhaled analgesia (MEOPA).
|
Performed in consultation under local anesthesia and inhaled analgesia, using a manual vacuum aspirator and appropriate cannula.
Post-procedure pelvic ultrasound to confirm complete evacuation.
|
|
Comparador Ativo: Electric aspiration in the operating room under general or regional anesthesia. Electric aspiration
Electric aspiration in the operating room under general or regional anesthesia.
Performed in the operating room under general or regional anesthesia, using an electric suction device and appropriate cannula.
Post-procedure pelvic ultrasound to confirm complete evacuation.
|
Performed in the operating room under general or regional anesthesia, using an electric suction device and appropriate cannula.
Post-procedure pelvic ultrasound to confirm complete evacuation.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Incremental cost-utility ratio (ICUR)
Prazo: 3 months
|
Incremental cost per quality-adjusted life year (QALY) gained of outpatient MVA compared to operating room EA, from a collective perspective.
|
3 months
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Annual net financial benefit for health insurance over up to 5 years of different development scenarios for manual vacuum aspiration in consultation for the management of pregnancies terminated before 12 weeks of gestation
Prazo: up to 5 years
|
Annual net financial benefit for health insurance over up to 5 years of different development scenarios for manual vacuum aspiration in consultation for the management of pregnancies terminated before 12 weeks of gestation
|
up to 5 years
|
|
To compare the two management strategies in terms of success and intraoperative and postoperative complications
Prazo: 1 month
|
To compare the two management strategies in terms of success and intraoperative and postoperative complications
|
1 month
|
|
To assess patient satisfaction
Prazo: day 1 and 2
|
To assess patient satisfaction: A numerical scale (NS) (0-10) on Days 1 and 2. |
day 1 and 2
|
|
To compare the two strategies (electric suction versus manual vacuum kit suction)
Prazo: days 0, 1,7 and 1 and 3 months
|
To compare the two strategies (electric suction versus manual vacuum kit suction), measurement of: ●Pain via NS (a scale from 0 to 10) on Day 0 (before the procedure, 30 min after the procedure +/- 30 min), Days 1, 7, 1, and 3 |
days 0, 1,7 and 1 and 3 months
|
|
The risk factors for failure
Prazo: 3 months
|
The risk factors for failure at M3 studied will be: the term of the terminated pregnancy, patient compliance, patient satisfaction (numerical scale (from 0 to 10), patient characteristics (age).
|
3 months
|
|
Satisfaction with the patient's care by medical staff
Prazo: day 0 and 1 month
|
Satisfaction with the patient's care by medical staff will be assessed using an EN (numerical scale 0 to 10) at D0 and M1
|
day 0 and 1 month
|
|
Patient having been pregnant in days
Prazo: 12 months
|
Patient having been pregnant at 12 months, pregnancy outcome and time to conception in days.
|
12 months
|
|
To assess patient satisfaction
Prazo: day 1 and 2 and 1 month et 3 month
|
To assess patient satisfaction: A numerical scale (NS) (0-10) on Days 1 and 2. HADS (Hospital Anxiety and Depression Scale) and PCL-5 questionnaires at 1 and 3 months |
day 1 and 2 and 1 month et 3 month
|
|
To assess patient satisfaction
Prazo: 1 and 3 months
|
HADS (Hospital Anxiety and Depression Scale) and PCL-5 questionnaires at 1 and 3 months
|
1 and 3 months
|
|
To compare the two strategies (electric suction versus manual vacuum kit suction)
Prazo: Day 0, 1,7 and 1 and 3 months
|
To compare the two strategies (electric suction versus manual vacuum kit suction), measurement of: ●Pain via NS (a scale from 0 to 10) on Day 0 (before the procedure, 30 min after the procedure +/- 30 min), Days 1, 7, 1, and 3 |
Day 0, 1,7 and 1 and 3 months
|
|
To compare the two strategies (electric suction versus manual vacuum kit suction)
Prazo: Day 0 to 7
|
To compare the two strategies (electric suction versus manual vacuum kit suction), measurement of: ●Analgesic consumption (type, quantity, and duration) from Day 0 to 7 |
Day 0 to 7
|
|
To compare the two strategies (electric suction versus manual vacuum kit suction)
Prazo: Day 0 to 7
|
To compare the two strategies (electric suction versus manual vacuum kit suction), measurement of: ●Number of pads used per day (Higham score) from Days 1 to 7 |
Day 0 to 7
|
|
To compare the two strategies (electric suction versus manual vacuum kit suction)
Prazo: Day 0
|
To compare the two strategies (electric suction versus manual vacuum kit suction), measurement of:
|
Day 0
|
|
To compare the two strategies (electric suction versus manual vacuum kit suction)
Prazo: 1 and 3 months
|
To compare the two strategies (electric suction versus manual vacuum kit suction) ● Postoperative complications will include:Perioperative bleeding greater than 200 ml (Higham score), infection (temperature >38°C and pelvic symptoms) …classified according to the Calvien and Dindo criteria, at M1, the persistence of abnormal bleeding, trophoblastic retention, at M3, the presence of amenorrhea outside the context of a new pregnancy |
1 and 3 months
|
|
To compare the two strategies (electric suction versus manual vacuum kit suction)
Prazo: 1 et 3 months
|
To compare the two strategies (electric suction versus manual vacuum kit suction), measurement of: ●quality of life questionnaires EQ-5D-5L, PGI-I at M1 and M3 |
1 et 3 months
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Thibault Thubert, Pr, Nantes university hospital
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Estimado)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- RC24_0471
- 2025-A00724-45 (Outro identificador: ANSM)
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Descrição do plano IPD
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .